肠道菌群与银屑病关系的研究进展

doi:10.3760/cma.j.issn.0412-4030.2019.05.018

Abstract

Abstract: 【Abstract】 Psoriasis is a chronic recurrent inflammatory skin disease, and its pathogenesis is still unclear. At present, it is believed that immune, genetic and environmental factors play important roles in the occurrence of psoriasis. More and more studies have indicated that the imbalance of intestinal flora is associated with immune diseases, especially inflammatory bowel disease. The pathogenesis and clinical manifestations of psoriasis are similar to those of inflammatory bowel disease, and psoriasis is proved to be associated with changes in intestinal microbial flora. This review discusses the association between the imbalance of intestinal flora and psoriasis.

Key words: Psoriasis, Imbalance of intestinal flora

Wang Liwei, Luo Lingling, Cui Pan′gen, Li Min. Relationship between intestinal flora and psoriasis[J].Chinese Journal of Dermatology, 2019, 52(5): 357-360.

References ［51］

［1］	Costello ME, Ciccia F, Willner D, et al. Brief report: intestinal dysbiosis in ankylosing spondylitis［J］. Arthritis Rheumatol, 2015,67（3）:686⁃691. doi: 10.1002/art.38967.
［2］	Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system［J］. Nat Immunol, 2013,14（7）:676⁃684. doi: 10.1038/ni.2640.
［3］	Felix KM, Tahsin S, Wu HJ. Host⁃microbiota interplay in mediating immune disorders［J］. Ann N Y Acad Sci, 2018,1417（1）:57⁃70. doi: 10.1111/nyas.13508.
［4］	Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system［J］. Nat Rev Immunol, 2017,17（4）:219⁃232. doi: 10.1038/nri.2017.7.
［5］	de Oliveira GLV, Leite AZ, Higuchi BS, et al. Intestinal dysbiosis and probiotic applications in autoimmune diseases［J］. Immunology, 2017,152（1）:1⁃12. doi: 10.1111/imm.12765.
［6］	Delzenne NM, Cani PD, Everard A, et al. Gut microorganisms as promising targets for the management of type 2 diabetes［J］. Diabetologia, 2015,58（10）:2206⁃2217. doi: 10.1007/s00125⁃015⁃3712⁃7.
［7］	Neuman H, Koren O. The gut microbiota: a possible factor influencing systemic lupus erythematosus［J］. Curr Opin Rheumatol, 2017,29（4）:374⁃377. doi: 10.1097/BOR.000000000 0000395.
［8］	Maeda Y, Kumanogoh A, Takeda K. Altered composition of gut microbiota in rheumatoid arthritis patients［J］. Nihon Rinsho Meneki Gakkai Kaishi, 2016,39（1）:59⁃63. doi: 10.2177/jsci.39. 59.
［9］	Becker C, Neurath MF, Wirtz S. The intestinal microbiota in inflammatory bowel disease［J］. ILAR J, 2015,56（2）:192⁃204. doi: 10.1093/ilar/ilv030.
［10］	Zákostelská Z, Málková J, Klimešová K, et al. Intestinal microbiota promotes psoriasis⁃like skin inflammation by enhancing Th17 response［J/OL］. PLoS One, 2016,11（7）:e0159539. doi: 10.1371/journal.pone.0159539.
［11］	Christophers E. Psoriasis⁃⁃epidemiology and clinical spectrum［J］. Clin Exp Dermatol, 2001,26（4）:314⁃320.
［12］	Skov L, Baadsgaard O. Bacterial superantigens and inflammatory skin diseases［J］. Clin Exp Dermatol, 2000,25（1）:57⁃61.
［13］	Fry L, Baker BS. Triggering psoriasis: the role of infections and medications［J］. Clin Dermatol, 2007,25（6）:606⁃615. doi: 10. 1016/j.clindermatol.2007.08.015.
［14］	Williams JP, Meyers JA. Immune⁃mediated inflammatory disorders （I.M.I.D.s）: the economic and clinical costs［J］. Am J Manag Care, 2002,8（21 Suppl）:S664⁃S681.
［15］	Harlan WR, Meyer A, Fisher J. Inflammatory bowel disease: epidemiology, evaluation, treatment, and health maintenance［J］. N C Med J, 2016,77（3）:198⁃201. doi: 10.18043/ncm.77.3.198.
［16］	Dogra S, Mahajan R. Psoriasis: epidemiology, clinical features, co⁃morbidities, and clinical scoring［J］. Indian Dermatol Online J, 2016,7（6）:471⁃480. doi: 10.4103/2229⁃5178.193906.
［17］	Skroza N, Proietti I, Pampena R, et al. Correlations between psoriasis and inflammatory bowel diseases［J］. Biomed Res Int, 2013,2013:983902. doi: 10.1155/2013/983902.
［18］	Pietrzak D, Pietrzak A, Krasowska D, et al. Digestive system in psoriasis: an update［J］. Arch Dermatol Res, 2017,309（9）:679⁃693. doi: 10.1007/s00403⁃017⁃1775⁃7.
［19］	Vlachos C, Gaitanis G, Katsanos KH, et al. Psoriasis and inflammatory bowel disease: links and risks［J］. Psoriasis （Auckl）, 2016,6:73⁃92. doi: 10.2147/PTT.S85194.
［20］	McIlroy J, Ianiro G, Mukhopadhya I, et al. Review article: the gut microbiome in inflammatory bowel disease⁃avenues for microbial management［J］. Aliment Pharmacol Ther, 2018,47（1）:26⁃42. doi: 10.1111/apt.14384.
［21］	Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA⁃B27/human beta2 microglobulin transgenic rats［J］. J Clin Invest, 1996,98（4）:945⁃953. doi: 10.1172/JCI 118878.
［22］	Reveille JD. Genetics of spondyloarthritis⁃⁃beyond the MHC［J］. Nat Rev Rheumatol, 2012,8（5）:296⁃304. doi: 10.1038/nrrheum. 2012.41.
［23］	Negi S, Singh H, Mukhopadhyay A. Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: In⁃silico study［J/OL］. PLoS One, 2017,12（7）:e0180518. doi: 10.1371/journal.pone.0180518.
［24］	Luckey D, Gomez A, Murray J, et al. Bugs & us: the role of the gut in autoimmunity［J］. Indian J Med Res, 2013,138（5）:732⁃743.
［25］	Liu X, Zeng B, Zhang J, et al. Role of the gut microbiome in modulating arthritis progression in mice［J］. Sci Rep, 2016,6:30594. doi: 10.1038/srep30594.
［26］	Scarpa R, Manguso F, D′Arienzo A, et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms［J］. J Rheumatol, 2000,27（5）:1241⁃1246.
［27］	Stebbings S, Munro K, Simon MA, et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis［J］. Rheumatology （Oxford）, 2002,41（12）:1395⁃1401.
［28］	Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease［J］. Arthritis Rheumatol, 2015,67（1）:128⁃139. doi: 10. 1002/art.38892.
［29］	Tan L, Zhao S, Zhu W, et al. The Akkermansia muciniphila is a gut microbiota signature in psoriasis［J］. Exp Dermatol, 2018,27（2）:144⁃149. doi: 10.1111/exd.13463.
［30］	Eppinga H, Sperna WCJ, Thio HB, et al. Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa［J］. J Crohns Colitis, 2016,10（9）:1067⁃1075. doi: 10.1093/ecco⁃jcc/jjw070.
［31］	Everard A, Belzer C, Geurts L, et al. Cross⁃talk between Akkermansia muciniphila and intestinal epithelium controls diet⁃induced obesity［J］. Proc Natl Acad Sci U S A, 2013,110（22）:9066⁃9071. doi: 10.1073/pnas.1219451110.
［32］	Png CW, Lindén SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria［J］. Am J Gastroenterol, 2010,105（11）:2420⁃2428. doi: 10.1038/ajg.2010.281.
［33］	Bos JD, de Rie MA, Teunissen MB, et al. Psoriasis: dysregulation of innate immunity［J］. Br J Dermatol, 2005,152（6）:1098⁃1107. doi: 10.1111/j.1365⁃2133.2005.06645.x.
［34］	Perez⁃Lopez A, Behnsen J, Nuccio SP, et al. Mucosal immunity to pathogenic intestinal bacteria［J］. Nat Rev Immunol, 2016,16（3）:135⁃148. doi: 10.1038/nri.2015.17.
［35］	Johansson ME, Phillipson M, Petersson J, et al. The inner of the two Muc2 mucin⁃dependent mucus layers in colon is devoid of bacteria［J］. Proc Natl Acad Sci U S A, 2008,105（39）:15064⁃15069. doi: 10.1073/pnas.0803124105.
［36］	Johansson ME, Gustafsson JK, Sjöberg KE, et al. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model［J/OL］. PLoS One, 2010,5（8）:e12238. doi: 10.1371/journal.pone.0012238.
［37］	Asquith MJ, Stauffer P, Davin S, et al. Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis［J］. Arthritis Rheumatol, 2016,68（9）:2151⁃2162. doi: 10.1002/art.39681.
［38］	Tervaniemi MH, Katayama S, Skoog T, et al. NOD⁃like receptor signaling and inflammasome⁃related pathways are highlighted in psoriatic epidermis［J］. Sci Rep, 2016,6:22745. doi: 10.1038/srep22745.
［39］	McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD［J］. Gut, 2007,56（10）:1333⁃1336. doi: 10. 1136/gut.2006.115402.
［40］	Omenetti S, Pizarro TT. The Treg/Th17 Axis: a dynamic balance regulated by the gut microbiome［J］. Front Immunol, 2015,6:639. doi: 10.3389/fimmu.2015.00639.
［41］	Schnupf P, Gaboriau⁃Routhiau V, Sansonetti PJ, et al. Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world［J］. Curr Opin Microbiol, 2017,35:100⁃109. doi: 10.1016/j.mib.2017.03.004.
［42］	Jacobs JP, Braun J. Immune and genetic gardening of the intestinal microbiome［J］. FEBS Lett, 2014,588（22）:4102⁃4111. doi: 10.1016/j.febslet.2014.02.052.
［43］	Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T⁃cell development by a commensal bacterium of the intestinal microbiota［J］. Proc Natl Acad Sci U S A, 2010,107（27）:12204⁃12209. doi: 10.1073/pnas.0909122107.
［44］	Hayashi A, Sato T, Kamada N, et al. A single strain of Clostridium butyricum induces intestinal IL⁃10⁃producing macrophages to suppress acute experimental colitis in mice［J］. Cell Host Microbe, 2013,13（6）:711⁃722. doi: 10.1016/j.chom. 2013.05.013.
［45］	Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species［J］. Science, 2011,331（6015）:337⁃341. doi: 10.1126/science.1198469.
［46］	David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome［J］. Nature, 2014,505（7484）:559⁃563. doi: 10.1038/nature12820.
［47］	Vasseur P, Serres L, Jégou JF, et al. High⁃fat diet⁃induced IL⁃17A exacerbates psoriasiform dermatitis in a mouse model of steatohepatitis［J］. Am J Pathol, 2016,186（9）:2292⁃2301. doi: 10.1016/j.ajpath.2016.05.012.
［48］	Higashi Y, Yamakuchi M, Fukushige T, et al. High⁃fat diet exacerbates imiquimod⁃induced psoriasis⁃like dermatitis in mice［J］. Exp Dermatol, 2018,27（2）:178⁃184. doi: 10.1111/exd.13484.
［49］	Mullish BH, Quraishi MN, Segal JP, et al. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology （BSG） and Healthcare Infection Society （HIS） guidelines［J］. Gut, 2018,67（11）:1920⁃1941. doi: 10.1136/gutjnl⁃2018⁃316818.
［50］	Paramsothy S, Paramsothy R, Rubin DT, et al. Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta⁃analysis［J］. J Crohns Colitis, 2017,11（10）:1180⁃1199. doi: 10.1093/ecco⁃jcc/jjx063.
［51］	Kragsnaes MS, Kjeldsen J, Horn HC, et al. Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6⁃month, double⁃blind, randomised, placebo⁃controlled trial［J］. BMJ Open, 2018,8（4）:e019231. doi: 10.1136/bmjopen⁃2017⁃019231.

[1]	Chen Yiwen, Su Ting, Su Zhonglan. Association between psoriasis and STAT3 [J]. Chinese Journal of Dermatology, 2019, 52(7): 502-505.
[2]	Su Beibei, Gan Quan, Gan Caibin. Effects of metformin on inflammatory status and phosphorylated Stat3 expression in lesions of a psoriasis?like mouse model [J]. Chinese Journal of Dermatology, 2019, 52(7): 475-480.
[3]	Qin Hui, Zheng Jie. FTY720 ameliorates psoriasis by inhibiting infiltration of skin Interleukin 17-producing γδT cells [J]. Chinese Journal of Dermatology, 2019, 52(6): 395-400.
[4]	Hu Yu, Chen Min, Gu Heng. MicroRNA and lncRNA in psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 350-353.
[5]	Pan Jiaxu, Zhou Jing. NF?κB signaling pathway in psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(5): 361-363.
[6]	Zeng Jingxin, Tian Xin, Zhu Huilan, Zhang Xibao, Lin Ling, Zhang Lidan, Liu Weiyu, Luo Quan . Expression of miRNA-148a-3p in CD4⁺ T lymphocytes in peripheral blood of patients with psoriasis vulgaris and its clinical significance [J]. Chinese Journal of Dermatology, 2019, 52(4): 231-235.
[7]	Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China （2018 simplified edition） [J]. Chinese Journal of Dermatology, 2019, 52(4): 223-230.
[8]	Working Committee on Standardized Diagnosis and Treatment, China Dermatologist Association, Dermatological Surgical Equipment Group and Skin Phototherapy Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Clinical application of home narrow band ultraviolet B phototherapy: an expert consensus statement [J]. Chinese Journal of Dermatology, 2019, 52(3): 156-161.
[9]	Gao Yimeng, Jin Hongzhong. The role of neuropsychiatric factors in the occurrence of psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(3): 204-207.
[10]	Guan Xin, Zhang Chunlei. Evaluation of efficacy of infliximab in the long-term treatment of moderate and severe psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2019, 52(2): 86-89.
[11]	WANG Gang. Main adverse reactions in biological agents in dermatology and their strategies [J]. Chinese Journal of Dermatology, 2019, 52(2): 77-80.
[12]	Hu Yu, Luan Chao, Lian Ni, Hao Zhimin, Sun Yujie, Wang Yan, Gu Heng, Chen Min. Expression of proprotein convertase subtilisin/kexin type 9 in the plasma of patients with psoriasis and its effect on the activation of peripheral CD4+ T cells [J]. Chinese Journal of Dermatology, 2019, 52(2): 90-93.
[13]	Peng Chen, Chen Wenjuan, Yu Ning, Gao Yunlu, Yi Xuemei, Ding Yangfeng. The progress of relationship between psoriasis and microecology of skin and intestine [J]. Chinese Journal of Dermatology, 2019, 52(2): 135-137.
[14]	Xiong Juanjuan, Bi Jianping, Sun Dexiang, Li Nian, Lu Qiaoyun. Dermoscopic features of onychomycosis and nail psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(2): 106-110.
[15]	Na Liu Jie ZHENG. Tissue-resident memory T cells and psoriasis [J]. Chinese Journal of Dermatology, 2018, 51(8): 630-632.

Relationship between intestinal flora and psoriasis

PDF

Like

Knowledge

Abstract

Cite this article

share this article

References ［51］

Related Articles 15

Metrics

Comments

Recommended 10